Home          View all 329 MoA classes  

      

Enter a class name or drug name above to search the database.

CTLA-4-directed Antibody Interactions [MoA] Mechanism of Action Drugs

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
0003-2327 YERVOY ipilimumab E.R. Squibb & Sons, L.L.C. INJECTION 2011-03-25
0003-2328 YERVOY ipilimumab E.R. Squibb & Sons, L.L.C. INJECTION 2011-03-25
0310-4505 IMJUDO tremelimumab AstraZeneca Pharmaceuticals LP INJECTION, SOLUTION 2022-10-21
0310-4535 IMJUDO tremelimumab AstraZeneca Pharmaceuticals LP INJECTION, SOLUTION 2022-10-21

 Mechanism of Action Classification 

Loading full table content...